DGS Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
DGS Capital Management's BMY Position: Q1 2026 in Review
DGS Capital Management reduced its Bristol-Myers Squibb (BMY) stake by 36% in Q1 2026, selling an estimated $319K and leaving 9,857 shares worth $598K. The position accounts for 0.1% of the portfolio, ranked #199.
DGS Capital Management first reported a position in BMY in Q2 2025 and has held it in 4 quarters since. The position peaked at $827K in Q4 2025. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- DGS Capital Management held 9,857 shares of Bristol-Myers Squibb worth $598K as of Q1 2026.
- DGS Capital Management sold 5,471 Bristol-Myers Squibb shares in Q1 2026, an estimated $319K.
- Bristol-Myers Squibb made up 0.1% of DGS Capital Management's portfolio in Q1 2026, its #199 holding.
- DGS Capital Management first reported a position in Bristol-Myers Squibb in Q2 2025 and has held it in 4 quarters since.
- DGS Capital Management's Bristol-Myers Squibb position peaked at $827K in Q4 2025.
- 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on DGS Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.